2.38
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Infinity Pharmaceuticals Inc | INFI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 2.38 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.38 | USD |
Period:
Draw Mode:
Infinity Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 211.86M | 89.02M | 87.10M | $ 1.72M | $ - | -0.68 | -3.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 60.00k | 3.80% |
Infinity Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INFI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.00 | 2.46 | 1.81 | 2.12 | 2,067,967 | 0.38 | 19.0% |
| 1 Month | 2.53 | 2.60 | 1.81 | 2.21 | 1,389,262 | -0.15 | -5.93% |
| 3 Months | 3.39 | 3.765 | 1.81 | 2.77 | 1,559,072 | -1.01 | -29.79% |
| 6 Months | 3.50 | 3.89 | 1.48 | 2.72 | 4,498,998 | -1.12 | -32.0% |
| 1 Year | 3.06 | 5.98 | 1.48 | 3.05 | 3,560,514 | -0.68 | -22.22% |
| 3 Years | 1.30 | 5.98 | 0.60 | 2.80 | 1,388,536 | 1.08 | 83.08% |
| 5 Years | 1.38 | 5.98 | 0.60 | 2.63 | 1,219,181 | 1.00 | 72.46% |
Infinity Pharmaceuticals Description
| Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development. |
